Skip to main content
Journal cover image

Surgical treatment of malignant esophageal tumors in PUMC Hospital.

Publication ,  Journal Article
Guo, H; Li, Z; Zhang, F; Zhang, Z; Xu, L; Li, W; Wang, W; Wu, M
Published in: Chin Med Sci J
December 2001

To study how to prolong the postoperative survival time of the patients with malignant esophageal tumors. The clinical data of 1098 patients with malignant esophageal tumors from 1961 to 1992 were retrospectively analyzed. The deletion of fragile histamine triplet (FHIT) gene (a tumor suppressor gene) in 30 fresh esophageal samples obtained in 1996 was detected with PCR and RT-PCR method. The resectability was raised gradually and the operative morbidity and mortality decreased year by year, but there was no significant improvement on the postoperative 5-year survival rate. Delayed diagnosis and irradical resection influenced the long-term survival. The deletion of cDNA of FHIT gene was 64. 2% in esophageal cancer and 20% in the resected margin of the cancer. We believe that high-grade atypical hyperplasia in esophageal epithelium and deletion of FHIT gene in esophageal cancer and its resected margin are pathological and molecular markers for early diagnosis of esophageal cancer respectively, and the latter may be one of the molecular markers for the resection. Early diagnosis and treatment, radical, resection, and postoperative nutritional support are very important for the improvement of the postoperative survival time of the patients.

Duke Scholars

Published In

Chin Med Sci J

ISSN

1001-9294

Publication Date

December 2001

Volume

16

Issue

4

Start / End Page

214 / 217

Location

China

Related Subject Headings

  • Survival Rate
  • Retrospective Studies
  • Oncology & Carcinogenesis
  • Neoplasm Proteins
  • Middle Aged
  • Male
  • Loss of Heterozygosity
  • Humans
  • Genes, Tumor Suppressor
  • Gene Deletion
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Guo, H., Li, Z., Zhang, F., Zhang, Z., Xu, L., Li, W., … Wu, M. (2001). Surgical treatment of malignant esophageal tumors in PUMC Hospital. Chin Med Sci J, 16(4), 214–217.
Guo, H., Z. Li, F. Zhang, Z. Zhang, L. Xu, W. Li, W. Wang, and M. Wu. “Surgical treatment of malignant esophageal tumors in PUMC Hospital.Chin Med Sci J 16, no. 4 (December 2001): 214–17.
Guo H, Li Z, Zhang F, Zhang Z, Xu L, Li W, et al. Surgical treatment of malignant esophageal tumors in PUMC Hospital. Chin Med Sci J. 2001 Dec;16(4):214–7.
Guo, H., et al. “Surgical treatment of malignant esophageal tumors in PUMC Hospital.Chin Med Sci J, vol. 16, no. 4, Dec. 2001, pp. 214–17.
Guo H, Li Z, Zhang F, Zhang Z, Xu L, Li W, Wang W, Wu M. Surgical treatment of malignant esophageal tumors in PUMC Hospital. Chin Med Sci J. 2001 Dec;16(4):214–217.
Journal cover image

Published In

Chin Med Sci J

ISSN

1001-9294

Publication Date

December 2001

Volume

16

Issue

4

Start / End Page

214 / 217

Location

China

Related Subject Headings

  • Survival Rate
  • Retrospective Studies
  • Oncology & Carcinogenesis
  • Neoplasm Proteins
  • Middle Aged
  • Male
  • Loss of Heterozygosity
  • Humans
  • Genes, Tumor Suppressor
  • Gene Deletion